Recombinant Cell Lines

Cell lines for biological studies and drug screening


Recombinant Cell Lines for Drug Discovery and Development

CrownBio has developed a portfolio of recombinant cell lines that cover important targets and pathways in oncology.

Currently available cell lines include:

Recombinant Cell Lines

Product Name Catalog # Datasheet Species  
BTLA Cell Line C2044 Human Details/Order
CD27 Cell Line C2027 Human  
CD28 Cell Line C2017 Human  
CD30 Cell Line C2028 Human  
CD30L Cell Line C2022 Human  
CD40 Cell Line C2029 Human  
CD48 Cell Line C2030 Human  
CD73 Cell Line C2018 Human  
CD74 Cell Line C2042 Human  
CD80 Cell Line C2043 Human  
CD86 Cell Line C2031 Human  
CD137 Cell Line C2012 Human  
CD154 Cell Line C2041 Human  
CD160 Cell Line C2033 Human  
CD226 Cell Line C2023 Human  
CD244 Cell Line C2048 Human  
CD258/LIGHT Cell Line C2040 Human  
CD269 Cell Line C2045 Human  
CD276 Cell Line C2024 Human  
CTLA-4 Cell Line C2015 Human  
EGFR-G719S Cell Line C2035 Human  
EGFR-G719S/T263P Cell Line C2036 Human  
EGFR-DEL19 Cell Line C2037 Human  
EGFR-DEL19/T790M Cell Line C2038 Human  
EGFR-L858R Cell Line C2039 Human  
GITRL Cell Line C2046 Human  
GITR Cell Line C2011 Human  
HVEM Cell Line C2034 Human  
ICOS Cell Line C2016 Human  
ICOSLG Cell Line C2019 Human  
LAG3 Cell Line C2020 Human  
NF-kappa B-luc2 Cell Line C2026 Human  
OX40 Cell Line C2014 Human  
PD-1 Cell Line C2004 Human  
PD-L1 Cell Line C2005 Human  
PD-L2 Cell Line C2025 Human  
RANKL Cell Line C2013 Hamster  
SLAMF1 Cell Line C2047 Human  
TIM1 Cell Line C2032 Human  
TIM3 Cell Line C2021 Human  

PD-1 Cell Line Data

PD-1 Recombinant Cell Line Data

FACS Analysis of Cell Surface PD-1 Expression by an Anti-hPD-1 Antibody and Isotype Control Antibody

PD-L1 Cell Line Data

PD-L1 Recombinant Cell Line Data

FACS Analysis of Cell Surface PD-L1 Expression by an Anti-hPD-L1 Antibody and Isotype Control Antibody

ALK Kinase Fusion Screening

Our Kinase-Live cell lines are stable Ba/F3 clones expressing exogenous EML4-ALK fusion variants, including wild type and L1196M, F1174L, and C1156Y mutations. They are ideal for cell-based screening of potential ALK inhibitors that can overcome crizotinib resistance.

Product Name Catalog # Species
EML4-ALK Cell Line C2000 Mouse
EML4-ALK L1196M Cell Line C2001 Mouse
EML4-ALK F1174L Cell Line C2002 Mouse
EML4-ALK C1156Y Cell Line C2003 Mouse

EML4-ALK Cell Line Characterization Data

EML4-ALK Recombinant Cell Line Characterization Data

Characterization of EML4-ALK Fusion Protein Expression in Different EML4-ALK Stable Cell lines by Western Blot.
Protein Lysates from NCI-H2228 Cells Harboring EML4-ALK Fusion, and KARPAS-299 Cells Harboring NPM1-ALK Fusion,
were Compared Side by Side in the Same Blot. Negative Control: Parental Ba/F3 Cell Line Extract

BCR-ABL Kinase Fusion Screening

Our BCR-ABL (breakpoint cluster region – Abelson murine leukemia viral oncogene homolog 1) cell line is a stable cell line expressing the exogenous BCR-ABL fusion gene with T315I point mutation in the ABL kinase domain, which is present in most cases of chronic myelogenous leukemia (CML). This cell line is ideal for cell-based screening of potential kinase inhibitors.

Product Name Catalog # Species
BCR-ABL T315I Cell Line C2008 Mouse

BCR-ABL Characterization Data

Characterization of Drug Sensitivity in BCR-ABL T315I Recombinant Cell Line

Characterization of Drug Sensitivity in BCR-ABL T315I Cell Line, Catalog # C2008.
C2008 was Treated with 5 Different Inhibitors for 72 Hours in 96-Well Plates. Cell Viability was Measured
using CellTiter-Glo®. Dose Response Curve and  IC50s were Fitted and Calculated using GraphPad Prism

EGFR Cell Lines

EGFR (epidermal growth factor receptor) is a cell-surface receptor tyrosine kinase. Activation of this receptor has been associated with a number of cancers, including lung and colon cancer. The identification of EGFR as a driver gene has led to the development of anticancer therapeutic agents, including gefitinib, erlotinib, afatinib, osimertinib (AZD9291), and cetuximab. The EGFR T790M mutation causes resistance to first generation reversible EGFR inhibitors, including erlotinib, and has resulted in the development of new irreversible EGFR inhibitors such as afatinib and osimertinib.

Ba/F3, a murine interleukin-3 dependent pro-B cell line, is a popular system for exploring both kinases and their kinase inhibitors, because some protein kinases can render Ba/F3 cells independent of IL-3, while their inhibitors antagonize this effect. Our EGFR Cell Lines were generated using pLVX-puro lentivirus system to express EGFR and the EGFR T790M mutation.

Product Name Catalog # Species
EGFR Cell Line C2009 Mouse
EGFR-DEL19 Cell Line C2037 Mouse
EGFR-DEL19/T790M Cell Line C2038 Mouse
EGFR-G719S Cell Line C2035 Mouse
EGFR-G719S/T263P Cell Line C2036 Mouse
EGFR-L858R Cell Line C2039 Mouse
EGFR-T790M Cell Line C2010 Mouse

EGFR T790M Cell Line Characterization Data

EGFR T790M Recombinant  Cell Line Characterization Data

Characterization of EGFR and its Mutants Overexpressed in Stable Cell Lines by Western Blot.
1. Parental Ba/F3 Cell Line Showing No EGFR Expression, 2. EGFR Wild Type Cell Line Expression,
3. Parental Ba/F3 Cell Line No EGFR Expression, and 4. EGFR-T790M Mutant Cell Line Expression

EGFR T790M Recombinant Cell Line Characterization Data

Characterization of Drug Sensitivity in Ba/F3 EGFR T790M Cell Line, Catalog # C2010.
C2010 was Treated with 4 Different Inhibitors for 72 hours in 96-Well Plates. Cell Viability was
Measured using CellTiter-Glo. Dose Response Curves IC50s  Fitted and Calculated using GraphPad Prism

Wnt Pathway Reporter Cell Line

Our 293T Wnt Luciferase Cell Line provides a convenient tool for screening of inhibitors or activators of Wnt signaling pathway, which is frequently activated abnormally in many human cancers. It is a HEK 293T cell clone stably integrated with Wnt reporter expression cassette with the firefly luciferase gene under the control of promoter containing 14 TCF-binding sites. The Wnt reporter expression is robustly induced by exogenous Wnt stimulation, which can be easily measured by the luciferase activity.

Pathway Reporter

Product Name Catalog # Species Protocol  
Wnt Luciferase Cell Line C2006 Human PDF

Wnt Luciferase Data

Wnt Luciferase Recombinant Cell Line Data

Wnt Luciferase Cells (C2006) Seeded in 96-Well Plates Stimulated with Soluble Wnt3a and R-spondin 2 in the Absence and Presence of Wnt Inhibitory Protein LGR5-Fc or DKK1 for 20h, Followed by Luciferase Activity Measurement


To receive pricing or for any product related questions contact us at:

Crown Bioscience Inc. Life Science Division
3375 Scott Blvd., Suite 108, Santa Clara, CA 95054

Tel: 855.827.6968 Email:
Fax: 866.745.6215 Ordering Terms & Conditions

Ask a Question / Request a Quote

Complete the form below to receive additional information about recombinant cell lines, or call:

+1 855 827 6968
6am - 5pm (PST)